We have 3 of 22 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
OBJECTIVE To evaluate long-term safety and efficacy of once-weekly lonapegsomatropin in adults with growth hormone (GH) deficiency. METHODS This 52-week, multicenter, open-label extension trial enrolled adults with GH deficiency who completed the 38-week phase 3 foresiGHt trial, in which participants received lonapeg...
The review discusses practical aspects of dosing and monitoring across age groups and addresses use in special populations and during the transition period from paediatric to adult care, including patient preference and the impact on metabolism, bone health and muscle strength.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
